Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study

The standard treatment for advanced hepatocellular carcinoma (HCC) is sorafenib, a multikinase inhibitor of tumor cell proliferation and angiogenesis. Hyperthermia inhibits angiogenesis and promotes apoptosis. Potential synergic antiangiogenic and proapoptotic effects represent the rationale for com...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: GADALETA-CALDAROLA, GENNARO, INFUSINO, STEFANIA, GALISE, IDA, RANIERI, GIROLAMO, VINCIARELLI, GIANLUCA, FAZIO, VITO, DIVELLA, ROSA, DANIELE, ANTONELLA, FILIPPELLI, GIANFRANCO, GADALETA, COSMO DAMIANO
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2014
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4156230/
https://ncbi.nlm.nih.gov/pubmed/25202410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2376
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller